Ticker Scorecard - MNKD Basics Company: MannKind Corporation IPO Date: July 28, 2004 Sector: Healthcare Industry: Biotech Market Cap: $1.59B Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.04% Avg Daily Range (30 D): $0.08 | 1.43% Avg Daily Range (90 D): $0.11 | 1.72% Institutional Daily Volume Avg Daily Volume: 1.48M Avg Daily Volume (30 D): 1.57M Avg Daily Volume (90 D): 2.01M Trade Size Avg Trade Size (Sh.): 169 Avg Trade Size (Sh.) (30 D): 113 Avg Trade Size (Sh.) (90 D): 127 Institutional Trades Total Inst.Trades: 3,547 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $1.37M Avg Inst. Trade (90 D): $2.01M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.8M Avg Closing Trade (30 D): $1.48M Avg Closing Trade (90 D): $2.12M Avg Closing Volume: 344.22K     News Sep 30, 2024 @ 10:00 AM More Adults With Type 1 Diabetes Achieved A1C Goal... Source: Mannkind Corporation Jun 27, 2024 @ 5:55 PM "Rule Breaker Investing" Market Cap Game Show: Bil... Source: newsfeedback@fool.com (Motley Fool Staff) Jun 22, 2024 @ 12:00 PM INHALE-3 Study Reveals Positive Readout in Head-to... Source: MannKind Jun 5, 2024 @ 10:45 AM Inhale-3 Study Results to be Presented During a 90... Source: MannKind May 29, 2024 @ 12:45 PM MannKind to Establish Boston-Area Research & Devel... Source: MannKind Financials   TTM Q3 2024 Q2 2024 Basic EPS $.08 $.04 $-.01 Diluted EPS $.08 $.04 $-.01 Revenue $ 267.2M $ 70.08M $ 72.39M Gross Profit $ 248.47M $ 66.88M $ 66.78M Net Income / Loss $ 21.57M $ 11.55M $ -2.01M Operating Income / Loss $ 53.95M $ 12.76M $ 16.61M Cost of Revenue $ 18.74M $ 3.2M $ 5.61M Net Cash Flow $ -19.91M $ -34.27M $ -95.9M PE Ratio 0.00     Splits Mar 03, 2017:   5:1